| 英文名稱 | Mobocertinib (TAK-788) | 
|---|---|
| 中文名稱 | 莫博替尼 | 
| CAS號 | 1847461-43-1 | 
| 分子式 | C32H39N7O4 | 
| 分子量 | 585.70 | 
| 外觀 | Off-white to light yellow powder | 
| 儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). | 
| 英文名稱 | Mobocertinib (TAK-788) | 
|---|---|
| 中文名稱 | 莫博替尼 | 
| CAS號 | 1847461-43-1 | 
| 分子式 | C32H39N7O4 | 
| 分子量 | 585.70 | 
| 外觀 | Off-white to light yellow powder | 
| 儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). | 
Mobocertinib (TAK-788; AP-32788; Exkivity), a drug used for the treatment of non-small cell lung cancer (NSCLC), is a novel, highly potent, irreversible and orally bioavailable inhibitor of EGFR and HER2 oncogenic mutants (e.g. exon 20 insertions), and exhibits high selectivity over WT EGFR.